4.4 Article

GFI1B controls its own expression binding to multiple sites

Journal

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
Volume 95, Issue 1, Pages 36-46

Publisher

FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.2009.012351

Keywords

GFI1B; controls; multiple sites

Categories

Funding

  1. Spanish Ministry of Science [SAF2005-04709/]
  2. Ramon y Cajal Program
  3. Medical Research Council [G1000801f] Funding Source: researchfish

Ask authors/readers for more resources

Background Transcription factors play essential roles in both normal and malignant hematopoiesis. This is the case for the growth factor independent 1b (GFI1B) transcription factor, which is required for erythroid and megakaryocytic differentiation and over-expressed in leukemic patients and cell lines. Design and Methods To investigate GFI1B regulation, we searched for multispecies conserved non-coding elements between GFI1B and neighboring genes. We used a formaldehyde-assisted isolation of regulatory elements (FAIRE) assay and DNasel hypersensitivity to assess the chromatin conformation of these sites. Next, we analyzed transcription factor binding and histone modifications at the GFI1B locus including the conserved non-coding elements by a chromatin immunoprecipitation assay. Finally, we studied the interaction of the GFI1B promoter and the conserved non-coding elements with the chromatin conformation capture technique and used immunofluorescence to evaluate GFI1B levels in individual cells. Results We localized several conserved non-coding elements containing multiple erythroid specific transcription factor binding sites at the GFI1B locus. In GFI1B-expressing cells a subset of these conserved non-coding elements and the promoter adopt a close spatial conformation, localize with open chromatin sites, harbor chromatin modifications associated with gene activation and bind multiple transcription factors and co-repressors. Conclusions Our findings indicate that GFI1B regulatory elements behave as activators and repressors. Different protein levels within a cell population suggest that cells must activate and repress GFI1B continuously to control its final level. These data are consistent with a model of GFI1B regulation in which GFI1B binds to its own promoter and to the conserved non-coding elements as its levels rise. This would attract repressor complexes that progressively down-regulate the gene. GFI1B expression would decrease until a stage at which the activating complexes predominate and expression increases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Microbiology

Seroprevalence and Trends of HTLV-1/2 among Blood Donors of Santo Domingo, Dominican Republic, 2012-2017

Emiliana Eusebio-Ponce, Francisco Javier Candel, Robert Paulino-Ramirez, Irene Serrano-Garcia, Eduardo Anguita

Summary: This study analyzed the seroprevalence and trends of HTLV-1/2 among blood donors in Santo Domingo, Dominican Republic, finding a period prevalence of 0.26% and a marked predominance of replacement donation. The study showed a relatively low and steady trend of HTLV-1/2 seroprevalence in the region during the studied period.

REVISTA ESPANOLA DE QUIMIOTERAPIA (2021)

Article Infectious Diseases

Autoimmune neutropenia associated with influenza virus infection in childhood: a case report

Ignacio Callejas Caballero, Marta Illan Ramos, Arantxa Berzosa Sanchez, Eduardo Anguita, Jose Tomas Ramos Amador

Summary: Severe neutropenia in infants and children, although usually benign, can potentially lead to life-threatening infections. Autoimmune neutropenia is a rare hematological disorder characterized by the destruction of neutrophils induced by autoantibodies, often triggered by viral infections. Conservative management may suffice for cases with a benign course of the disease.

BMC INFECTIOUS DISEASES (2021)

Article Multidisciplinary Sciences

Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM)

Julia Gonzalez-Rincon, Jose A. Garcia-Vela, Sagrario Gomez, Belen Fernandez-Cuevas, Sara Nova-Gurumeta, Nuria Perez-Sanz, Miguel Alcoceba, Marcos Gonzalez, Eduardo Anguita, Javier Lopez-Jimenez, Eva Gonzalez-Barca, Lucrecia Yanez, Ernesto Perez-Persona, Javier de la Serna, Miguel Fernandez-Zarzoso, Guillermo Deben, Francisco J. Penalver, Maria C. Fernandez, Jaime Perez de Oteyza, M. angeles Andreu, M. angeles Ruiz-Guinaldo, Raquel Paz-Arias, M. Dolores Garcia-Malo, Valle Recasens, Rosa Collado, Raul Cordoba, Belen Navarro-Matilla, Margarita Sanchez-Beato, Jose A. Garcia-Marco

Summary: Chronic Lymphocytic Leukemia (CLL) is the most common leukemia in Western countries, known for its variable clinical course influenced by mutational status of genes. Studies have identified recurrent somatic mutations in genes related to cell cycle, DNA repair, RNA metabolism, and splicing. Results of this study suggest that, except for TP53 gene mutations, the mutational status of other genes does not seem to affect the positive outcomes of rituximab maintenance therapy in CLL patients after frontline FCR treatment.

PLOS ONE (2021)

Article Medicine, General & Internal

Impact of BCR-ABL1 Transcript Type on Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated with Imatinib

Silvia Marce, Blanca Xicoy, Olga Garcia, Marta Cabezon, Natalia Estrada, Patricia Velez, Concepcion Boque, Miguel Sagues, Anna Angona, Raul Teruel-Montoya, Francisca Ferrer-Marin, Paula Amat, Juan Carlos Hernandez-Boluda, Mariana M. Ibarra, Eduardo Anguita, Montserrat Cortes, Andres Fernandez-Ruiz, Sandra Fontanals, Lurdes Zamora

Summary: The study found that the expression of e14a2 or e13a2 transcripts in chronic myeloid leukemia (CML) patients does not affect treatment outcomes. Specifically, e14a2 transcripts are associated with better molecular responses in the first 6 months of treatment, while e13a2 is linked to improved long-term overall survival.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Hematology

Engraftment characterization of risk-stratified AML in NSGS mice

Rafael Diaz de la Guardia, Talia Velasco-Hernandez, Francisco Gutierrez-Aguera, Heleia Roca-Ho, Oscar Molina, Cesar Nombela-Arrieta, Alex Bataller, Jose Luis Fuster, Eduardo Anguita, Susana Vives, Lurdes Zamora, Josep Nomdedeu, Maria Teresa Gomez-Casares, Manuel Ramirez-Orellana, Helene Lapillonne, Veronica Ramos-Mejia, Juan Carlos Rodriguez-Manzaneque, Clara Bueno, Belen Lopez-Millan, Pablo Menendez

Summary: AML is a highly heterogeneous disease, and patient stratification based on risk is crucial for treatment decisions. Using NSGS mice, researchers found that engraftment levels were mostly independent of risk group, with HR AML patients showing significantly superior engraftment compared to FR or IR patients. These findings provide a valuable platform for testing targeted therapies in risk-stratified AML patient samples.

BLOOD ADVANCES (2021)

Article Cell Biology

Developmental Disruption of Erbb4 in Pet1+ Neurons Impairs Serotonergic Sub-System Connectivity and Memory Formation

Candela Barettino, Alvaro Ballesteros-Gonzalez, Andres Aylon, Xavier Soler-Sanchis, Leticia Orti, Selene Diaz, Isabel Reillo, Francisco Garcia-Garcia, Francisco Jose Iborra, Cary Lai, Nathalie Dehorter, Xavier Leinekugel, Nuria Flames, Isabel Del Pino

Summary: This study investigates the role of the tyrosine kinase receptor ErbB4 in the formation and function of serotonergic circuits by disrupting gene expression specific to serotonergic subsets. It shows that ErbB4 expression in a subset of serotonergic neurons is necessary for axonal arborization to the forebrain, but not for innervation of other targets. Additionally, ErbB4 deficiency in serotonergic neurons leads to specific behavioral deficits in memory processing, involving aversive or social components.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Biomarkers of stable and decompensated phases of heart failure with preserved ejection fraction

Eduardo Anguita, Alberto Chaparro, Francisco Javier Candel, Carlos Ramos-Acosta, Neus Martinez-Micaelo, Nuria Amigo, Maria Jose Torrejon, Guillermo Llopis-Garcia, Maria del Mar Suarez-Cadenas, Mayra Matesanz, Juan Gonzalez del Castillo, Francisco Javier Martin-Sanchez

Summary: This study aimed to identify blood biomarkers related to mitochondrial and cell metabolism in older patients with acute and stable HFpEF. The results showed that patients in the decompensated phase had increased mitochondrial superoxide production and mass, lower mitochondrial DNA copy number and LDHB expression, and higher lactate level compared to the stable phase. The stable phase was characterized by a sharp reduction in formate level. The findings highlighted the relationship between HFpEF and aging and suggested potential therapeutic targets for monitoring and treatment of patients.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2022)

Article Oncology

The Multi-Kinase Inhibitor EC-70124 Is a Promising Candidate for the Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia

Belen Lopez-Millan, Paula Costales, Francisco Gutierrez-Aguera, Rafael Diaz de la Guardia, Heleia Roca-Ho, Meritxell Vinyoles, Alba Rubio-Gayarre, Remi Safi, Julio Castano, Paola Alejandra Romecin, Manuel Ramirez-Orellana, Eduardo Anguita, Irmela Jeremias, Lurdes Zamora, Juan Carlos Rodriguez-Manzaneque, Clara Bueno, Francisco Moris, Pablo Menendez

Summary: The study found that EC-70124 is a promising and safe agent for the treatment of FLT3-ITDMUT AML, exhibiting robust and specific antileukemia activity while sparing healthy hematopoietic cells.

CANCERS (2022)

Article Multidisciplinary Sciences

Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA

Ricardo Sanchez, Sara Dorado, Yanira Ruiz-Heredia, Alejandro Martin-Munoz, Juan Manuel Rosa-Rosa, Jordi Ribera, Olga Garcia, Ana Jimenez-Ubieto, Gonzalo Carreno-Tarragona, Maria Linares, Laura Rufian, Alexandra Juarez, Jaime Carrillo, Maria Jose Espino, Mercedes Caceres, Sara Exposito, Beatriz Cuevas, Raul Vanegas, Luis Felipe Casado, Anna Torrent, Lurdes Zamora, Santiago Mercadal, Rosa Coll, Marta Cervera, Mireia Morgades, Jose Angel Hernandez-Rivas, Pilar Bravo, Cristina Seri, Eduardo Anguita, Eva Barragan, Claudia Sargas, Francisca Ferrer-Marin, Jorge Sanchez-Calero, Julian Sevilla, Elena Ruiz, Lucia Villalon, Maria del Mar Herraez, Rosalia Riaza, Elena Magro, Juan Luis Steegman, Chongwu Wang, Paula de Toledo, Valentin Garcia-Gutierrez, Rosa Ayala, Josep-Maria Ribera, Santiago Barrio, Joaquin Martinez-Lopez

Summary: In this study, a novel DNA-based next-generation sequencing (NGS) method was developed for the detection and monitoring of BCR::ABL1 kinase domain (KD) mutations in chronic myeloid leukemia (CML) and B-cell precursor acute lymphoblastic leukemia (ALL) Philadelphia (Ph)-positive patients. This method showed high sensitivity and specificity, and was able to detect mutations even in patients with low levels of disease.

SCIENTIFIC REPORTS (2022)

Article Pathology

A Novel Bead-Capture Nanopore Sequencing Method for Large Structural Rearrangement Detection in Cancer

Chloe L. Fisher, Richard Dillon, Eduardo Anguita, Deborah J. Morris-Rosendahl, Ali R. Awan

Summary: This study presents a novel method for genomic rearrangement detection based on third-generation long-read sequencing. The method overcomes time and cost issues and demonstrates its utility in patients with acute myeloid leukemia. It not only detects expected rearrangements, but also discovers novel translocations.

JOURNAL OF MOLECULAR DIAGNOSTICS (2022)

Article Endocrinology & Metabolism

Free triiodothyronine levels and age influences the metabolic profile and COVID-19 severity parameters in euthyroid and levothyroxine-treated patients

Ines Amich, Eduardo Anguita, Silvia Escribano-Serrat, Cristina Alvarez, Diego Rodriguez-Munoz, Veronica Garcia, Rocio Bello, Jose Alberto Pena-Pedrosa, Neus Martinez-Micaelo, Nuria Amigo, Pablo Ortiz, Maria Jose Torrejon, Lisardo Bosca, Javier Martin-Sanchez, Ana Aranda, Susana Alemany

Summary: Metabolic reprogramming is important in fighting COVID-19 infection, and thyroid hormones play a key role in regulating metabolism. This study compared euthyroid patients and those with hypothyroidism treated with levothyroxine (LT4) in terms of biochemical, metabolomic, cytokine, and clinical parameters. No significant differences were found between the two groups, except for TSH and ferritin levels in the ward and TSH and FT4 levels in the ICU. Age was negatively correlated with FT3, and patients with low FT3 and older age had worse prognosis and higher levels of IL-6 and IL-10. A metabolomic cluster indicative of a high ketogenic profile was identified in non-critical hospitalized patients with low FT3 levels.

FRONTIERS IN ENDOCRINOLOGY (2022)

Article Biochemistry & Molecular Biology

An NMR-Based Model to Investigate the Metabolic Phenoreversion of COVID-19 Patients throughout a Longitudinal Study

Ruben Gil-Redondo, Ricardo Conde, Maider Bizkarguenaga, Chiara Bruzzone, Ana Lain, Beatriz Gonzalez-Valle, Milagros Iriberri, Carlos Ramos-Acosta, Eduardo Anguita, Juan Ignacio Arriaga Lariz, Pedro Pablo Espana Yandiola, Miguel Angel Moran, Mario Ernesto Jimenez-Mercado, Leire Egia-Mendikute, Maria Luisa Seco, Hartmut Schaefer, Claire Cannet, Manfred Spraul, Asis Palazon, Nieves Embade, Shelly C. Lu, Julien Wist, Jeremy K. Nicholson, Jose M. Mato, Oscar Millet

Summary: This study investigated the natural history of COVID-19 disease at the molecular level and characterized the metabolic and immunological phenoreversion in hospitalized severe patients and non-hospitalized recovered patients. The findings suggest that acute patients experience metabolic and immunological dysregulation, resulting in a slower recovery time, while non-hospitalized recovered patients do not show any associated metabolic or immune alterations.

METABOLITES (2022)

Article Microbiology

SARS-CoV-2-encoded small RNAs are able to repress the host expression of SERINC5 to facilitate viral replication

Salvador Meseguer, Mari-Paz Rubio, Begona Lainez, Beatriz Perez-Benavente, Raul Perez-Moraga, Sergio Romera-Giner, Francisco Garcia-Garcia, Olalla Martinez-Macias, Antonio Cremades, Francisco J. Iborra, Oscar Candelas-Rivera, Fernando Almazan, Enric Esplugues

Summary: It has been found that levels of SERINC5 are reduced in COVID-19 patients, and the repression of SERINC5 expression may be caused by viral non-coding small RNAs (svRNAs).

FRONTIERS IN MICROBIOLOGY (2023)

Article Biochemistry & Molecular Biology

Each Cellular Compartment Has a Characteristic Protein Reactive Cysteine Ratio Determining Its Sensitivity to Oxidation

Ricardo Pires das Neves, Monica Chagoyen, Antonio Martinez-Lorente, Carlos Iniguez, Ana Calatrava, Juana Calabuig, Francisco J. Iborra

Summary: This study reveals the importance of thiol groups from cysteines in cellular response to ROS and their role in signaling. Different subcellular compartments have different amounts of these thiol groups, with the nucleolus having the highest concentration. These findings provide insights into the differential sensitivity of cells to ROS.

ANTIOXIDANTS (2023)

Letter Biochemistry & Molecular Biology

Chemotherapy induces cell plasticity; controlling plasticity increases therapeutic response

Francisco J. Iborra, Cristina Marti, Virtu Calabuig-Navarro, Petros Papadopoulos, Salvador Meseguer, Pedro M. Iborra, Francisco Garcia, Antonio Martinez-Lorente, Fernando Almazan, Juana Calabuig

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2023)

No Data Available